High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors

Statins as Anti-inflammatory Therapy in HIV Disease?

(2011) A. Carr   JOURNAL OF INFECTIOUS DISEASES

High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial

(2011) Anuradha Ganesan et al.   JOURNAL OF INFECTIOUS DISEASES

Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population

(2010) Sylvie Lang et al.   AIDS

Association Between Systemic Inflammation and Incident Diabetes in HIV-Infected Patients After Initiation of Antiretroviral Therapy

(2010) T. T. Brown et al.   DIABETES CARE

Association of Immunologic and Virologic Factors With Myocardial Infarction Rates in a US Healthcare System

(2010) Virginia A Triant et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort

(2010) Phyllis C Tien et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate versus Deferred Antiretroviral Therapy in Patients With HIV Infection

(2010) Jason V Baker et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection

(2010) Jacqueline Neuhaus et al.   JOURNAL OF INFECTIOUS DISEASES

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

(2009) Kimberly Y Smith et al.   AIDS

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

(2009) Priscilla Y Hsue et al.   AIDS

Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial

(2009) Elisabeth Aslangul et al.   AIDS

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: Results of the CAP (Comparative Atorvastatin Pleiotropic effects) study

(2009) Jacques Bonnet et al.   CLINICAL THERAPEUTICS

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

(2009) Paul M Ridker et al.   LANCET

Cardiovascular disease and HIV infection: host, virus, or drugs?

(2008) Esteban Martínez et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

(2008) Lewis H Kuller et al.   PLOS MEDICINE